The efficacy of venlafaxine in the treatment of women with stress urinary incontinence
- 16 July 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Archiv für Gynäkologie
- Vol. 279 (3), 343-348
- https://doi.org/10.1007/s00404-008-0729-x
Abstract
To examine the efficacy of venlafaxine, which is used as an antidepressant, in the treatment of stress urinary incontinence. The study was designed as a placebo-controlled, double-blind and randomized clinical study. Patients in Group 1 (n = 20) were administered 75 mg venlafaxine, those in Group 2 (n = 20) were administered placebo for 12 weeks. All the cases were evaluated in terms of weekly incontinence episode frequency (IEF), change in void interval (VI), the Incontinence Quality of Life (I-QOL) in weeks 0, 4, 8 and 12. Additionally, PGI-S was assessed at baseline and was followed by PGI-I evaluations in weeks 4, 8 and 12. Evaluations in weeks 0, 4, 8 and 12 did not show any significant difference in IEF, VI, IQOL and PGI-I values of placebo group (p > 0.05). However, in the patients who were administered venlafaxine declines in IEF and PGI-I values as well as the elevations in VI and IQOL scores showed significant changes parallel to the increasing follow-up period (p < 0.05). Nausea was observed in 40% of cases in venlafaxine group, and 15% of those in placebo group (p < 0.05). It was seen in our study that efficacy of venlafaxine started early and the clinical efficacy associated with the use of the drug continued in the following months. Venlafaxine should be considered a clinically efficient alternative drug in the treatment of SUI.Keywords
This publication has 14 references indexed in Scilit:
- Duloxetine, a Serotonin and Noradrenaline Reuptake Inhibitor (SNRI) for the Treatment of Stress Urinary Incontinence: A Systematic ReviewEuropean Urology, 2007
- Venlafaxine and Bladder FunctionClinical Neuropharmacology, 2005
- Venlafaxine-Induced Increase in Urinary Frequency in 3 WomenPublished by Physicians Postgraduate Press, Inc ,2004
- Validation of two global impression questionnaires for incontinenceAmerican Journal of Obstetrics and Gynecology, 2003
- Duloxetine versus placebo in the treatment of stress urinary incontinenceAmerican Journal of Obstetrics and Gynecology, 2002
- Comparative Affinity of Duloxetine and Venlafaxine for Serotonin and Norepinephrine Transporters in vitro and in vivo, Human Serotonin Receptor Subtypes, and Other Neuronal ReceptorsNeuropsychopharmacology, 2001
- The effects of a selective noradrenaline reuptake inhibitor on the urethra: an in vitro and in vivo studyBJU International, 2001
- Regional Brain Metabolic Changes in Patients With Major Depression Treated With Either Paroxetine or Interpersonal TherapyArchives of General Psychiatry, 2001
- Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL)Urology, 1999
- Quality of life of persons with urinary incontinence: Development of a new measureUrology, 1996